REQUEST A DEMO
Total
USD $0.00
Search more companies

Actavis D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Actavis D.O.O. Beograd Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Actavis D.O.O. was icorporated in 2008 by Actavis Holding CEE B.V. The Belgrade-based unit is active in the wholesale distribution of pharmaceutical products. The company operates as a regional representative for Serbia and Montenegro.

Headquarters
Djordja Stanojevica 12
Belgrade; Belgrade;

Contact Details: Purchase the Actavis D.O.O. Beograd report to view the information.

Website: http://www.actavis.rs

Basic Information
Total Employees:
Purchase the Actavis D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Actavis D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Actavis D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Actavis D.O.O. Beograd report to view the information.
Incorporation Date:
July 31, 2008
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Teva Serbia D.O.O. Beograd
100%
Company Performance
Financial values in the chart are available after Actavis D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
0.17%
Total operating revenue
2.23%
Operating profit (EBIT)
-26.98%
EBITDA
-22.96%
Net Profit (Loss) for the Period
-32.1%
Total assets
7%
Total equity
6.11%
Operating Profit Margin (ROS)
-1.81%
Net Profit Margin
-1.21%
Return on Equity (ROE)
-3.23%
Debt to Equity Ratio
-3.58%
Quick Ratio
-0.54%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?